COVID-19 Infection in a Patient with End-Stage Kidney Disease | Zendy

Dian Fu | Zendy; Bo Yang | Zendy; Jing Xu | Zendy; Zhiguo Mao | Zendy; Chenchen Zhou | Zendy; Cheng Xue | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

COVID-19 Infection in a Patient with End-Stage Kidney Disease

Author(s) -

Dian Fu,

Bo Yang,

Jing Xu,

Zhiguo Mao,

Chenchen Zhou,

Cheng Xue

Publication year - 2020

Publication title -

the nephron journals/nephron journals

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.951

H-Index - 72

eISSN - 2235-3186

pISSN - 1660-8151

DOI - 10.1159/000507261

Subject(s) - renal replacement therapy , medicine , covid-19 , intensive care medicine , kidney disease , isolation (microbiology) , dialysis , end stage kidney disease , hemodialysis , disease , uremia , end stage renal disease , coronavirus , stage (stratigraphy) , acute kidney injury , outbreak , infectious disease (medical specialty) , virology , bioinformatics , biology , paleontology

Since December 2019, the epidemic of coronavirus disease 2019 (COVID-19) has spread very rapidly in China and worldwide. In this article, we report on a 75-year-old man infected with 2019 novel coronavirus who has end-stage kidney disease (ESKD). COVID-19 patients with ESKD need isolation dialysis, but most of them cannot be handled in time due to limited continuous renal replacement therapy (CRRT) machines. CRRT provided benefits for this patient by removing potentially damaging toxins and stabilizing his metabolic and hemodynamic status. With the control of uremia and fluid status, this patient ended up with an uneventful post-CRRT course, absence of clinical symptoms, and negative PCR tests. Greater efforts are needed to decrease the mortality of COVID-19-infected ESKD patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research